Entradas por csanchez

Rev Esp Quimioter 2012:25(1):79-88

Prevention of perinatal group B Streptococcal disease. Updated Spanish recommendations                   J. I. ALÓS, A. ANDREU, L. ARRIBAS, L. CABERO, M. CUETO, J. LÓPEZ, J. C. MELCHOR, A. PUERTAS, M. DE LA ROSA, S. SALCEDO, M. SÁNCHEZ, M. J. SÁNCHEZ, R. TORREJÓN                                                           It has been a significant reduction in neonatal group B streptococcus (GBS) infection […]

Rev Esp Quimioter 2012:25(1):65-73

Analysis of treatments used in infections caused by Gram-positive multiresistant cocci in critically ill patients admitted to the ICU                   F. ÁLVAREZ-LERMA, M. PALOMAR, P. OLAECHEA, J. INSAUSTI, M. J. LÓPEZ, M. P. GRACIA, R. GIMENO, I. SEIJAS                                                           The appearance of new antimicrobials with activity against Gram-positive multiresistant cocci and knowledge of the limitations of […]

Rev Esp Quimioter 2012:25(1):56-64

Clinical characteristics and outcome of patients with pandemic 2009 Influenza A(H1N1)v virus infection admitted to hospitals with different levels of health-care                   M. GUTIÉRREZ-CUADRA, J.L. GONZÁLEZ-FERNÁNDEZ, P. RODRÍGUEZ-CUNDIN, C. FARIÑAS-ÁLVAREZ, M. V. SAN JUAN, J. A. PARRA, M. CARRASCOSA, M. C. FARIÑAS                                                          Background. The outcome of patients with influenza A 2009 (H1N1)v virus infection taking […]

Rev Esp Quimioter 2012:25(1):47-55

Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology                 F. CAFINI, D. SEVILLANO, L. ALOU, F. GÓMEZ-AGUADO, M. T. CORCUERA, N. GONZÁLEZ, J. GUINEA, J. PRIETO                                                            Objectives: the aims of the study were to explore the activity of total and free (according […]

Rev Esp Quimioter 2012:25(1):42-46

Phenotypes and mechanisms of resistance to macrolides and lincosamides in Streptococcus agalactiae isolates with clinical significance in an eight-year period (2002-2010)                 F. ARTILES, A. CAÑAS, I. ÁLAMO, B. LAFARGA                                  Introduction. Streptococcus agalactiae is the most prevalent agent of invasive disease in the newborn (sepsis, pneumonia, and meningitis), as well as an important cause of […]

Rev Esp Quimioter 2012:25(1):37-41

Antimicrobial resistance in clinical patterns of Pseudomonas aeruginosa                 M. M. CASAL, M. CAUSSE, F. RODRÍGUEZ-LÓPEZ, M. CASAL                                 Pseudomonas aeruginosa is an opportunistic microorganism that is frequently the cause of nosocomial infections. Multiple mechanisms are involved in its natural and acquired resistance to many of the antimicrobial agents commonly used in clinical practice. We performed […]

Rev Esp Quimioter 2012:25(1):31-36

Respiratory infections: etiology and patterns of resistance in the hospital general of Ciudad Real                     I. CLEMENTE, M. D. MAÑAS, J. MARTÍNEZ, C. MONROY, M. SIDAHI, J. YANES                                  Objectives. Understanding the impact on our work place of increasing antibiotic resistance in respiratory infections.Material and methods. We have performed a retrospective observational study […]

Rev Esp Quimioter 2012:25(1):25-30

Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures                 M. FAJARDO, R. HIDALGO, S. RODRÍGUEZ, C. GAONA, R. M. SÁNCHEZ, R. HERNÁNDEZ, E. MARTÍNEZ, J. L. CORDEROM. T. MARTÍNEZ-IZQUIERDO                              Introduction. Coagulase-negative-Staphylococci (CNS) are the major cause of bacteraemia and sepsis in newborns. CNS methicillin resistance and its loss […]

Rev Esp Quimioter 2012:25(1):17-24

Liposomal amphotericin B: a unique pharmacokinetic profile. An unfinished story                 J. R. AZANZA, J. BARBERÁN                             La anfotericina B en su formulación liposómica continúa siendo un fármaco de referencia en el tratamiento de las infecciones fúngicas sistémicas a pesar del tiempo transcurrido desde que se desarrolló. La ausencia de resistencias de los hongos, la farmacocinética, y […]

Rev Esp Quimioter 2012:25(1):10-16

Macrolides and staphylococcal biofilms                 J. PARRA-RUIZ, C. VIDAILLAC, M. J. RYBAK                             Medical device-associated infections represent a growing problem with limited or no therapeutic options beyond implant removal. Bacterial biofilm is the major and the final determinant of the poor prognosis of these difficult-to-treat infections. Due to the high antimicrobial resistance level of bacteria organized in […]